Literature DB >> 24309068

Adequate dietary vitamin D and calcium are both required to reduce bone turnover and increased bone mineral volume.

Alice M C Lee1, Rebecca K Sawyer1, Alison J Moore1, Howard A Morris1, Peter D O'Loughlin1, Paul H Anderson2.   

Abstract

Clinical studies indicate that the combination of vitamin D and dietary calcium supplementation is more effective for reducing fracture risk than either supplement alone. Our previous dietary studies demonstrated that an adequate serum 25-hydroxyvitamin D3 (25D) of 80nmol/L or more reduces bone RANKL expression, osteoclastogenesis and maintains the optimal levels of trabecular bone volume (BV/TV%) in young rats. The important clinical question of the interaction between vitamin D status, dietary calcium intake and age remains unclear. Hence, 9 month-old female Sprague-Dawley rats (n=5-6/group) were pair-fed a semi-synthetic diet containing varying levels of vitamin D (0, 2, 12 or 20IU/day) and dietary calcium (0.1% or 1%) for 6 months. At 15 months of age, animals were killed, for biochemical and skeletal analyses. While changes to serum 25D were determined by both dietary vitamin D and calcium levels, changes to serum 1,25-dihydroxyvitamin D3 (1,25D) were consistently raised in animals fed 0.1% Ca regardless of dietary vitamin D or vitamin D status. Importantly, serum cross-laps levels were significantly increased in animals fed 0.1% Ca only when combined with 0 or 2 IUD/day of vitamin D, suggesting a contribution of both dietary calcium and vitamin D in determining bone resorption activity. Serum 25(OH)D3 levels were positively correlated with both femoral mid-diaphyseal cortical bone volume (R(2)=0.24, P<0.01) and metaphyseal BV/TV% (R(2)=0.23, P<0.01, data not shown). In multiple linear regressions, serum 1,25(OH)2D3 levels were a negative determinant of CBV (R(2)=0.24, P<0.01) and were not a determinant of metaphyseal BV/TV% levels. These data support clinical data that reduced bone resorption and increased bone volume can only be achieved with adequate 25D levels in combination with high dietary calcium and low serum 1,25D levels. This article is part of a Special Issue entitled '16th Vitamin D Workshop'. Crown
Copyright © 2013. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Bone turnover; Calcium; Vitamin D

Mesh:

Substances:

Year:  2013        PMID: 24309068     DOI: 10.1016/j.jsbmb.2013.11.009

Source DB:  PubMed          Journal:  J Steroid Biochem Mol Biol        ISSN: 0960-0760            Impact factor:   4.292


  4 in total

Review 1.  Vitamin D Activity and Metabolism in Bone.

Authors:  Paul H Anderson
Journal:  Curr Osteoporos Rep       Date:  2017-10       Impact factor: 5.096

Review 2.  Vitamin D activities for health outcomes.

Authors:  Howard A Morris
Journal:  Ann Lab Med       Date:  2014-04-08       Impact factor: 3.464

3.  Calcium and vitamin-D deficiency marginally impairs fracture healing but aggravates posttraumatic bone loss in osteoporotic mice.

Authors:  Verena Fischer; Melanie Haffner-Luntzer; Katja Prystaz; Annika Vom Scheidt; Björn Busse; Thorsten Schinke; Michael Amling; Anita Ignatius
Journal:  Sci Rep       Date:  2017-08-03       Impact factor: 4.379

4.  Calcium Supplement Derived from Gallus gallus domesticus Promotes BMP-2/RUNX2/SMAD5 and Suppresses TRAP/RANK Expression through MAPK Signaling Activation.

Authors:  Han Seok Yoo; Gyung-Ji Kim; Da Hye Song; Kang-Hyun Chung; Kwon-Jai Lee; Dong-Hee Kim; Jeung Hee An
Journal:  Nutrients       Date:  2017-05-17       Impact factor: 5.717

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.